All In MedTech

FDA Clearance Tracker · K940661

STIEGMANN-GOFF ENDOSCOPIC LIGATOR

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Nov 28, 1994 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Nov 28, 1994

Substantially Equivalent

Time to decision

286 days

Received Feb 15, 1994. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K940661
Device name
STIEGMANN-GOFF ENDOSCOPIC LIGATOR
Applicant location
Tewksbury, MA
Received
Feb 15, 1994
Decided
Nov 28, 1994
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 876.4400

Every decision under product code MND

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code MND (Ligator, Esophageal).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for C.R. Bard, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.